These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24454902)

  • 21. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
    Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
    Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
    Zhan Y; Guo W; Zhang Y; Wang Q; Xu XJ; Zhu L
    Comput Math Methods Med; 2015; 2015():842784. PubMed ID: 26539246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
    Zhao H; Leppert JT; Peehl DM
    PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.
    Gu Y; Zou YM; Lei D; Huang Y; Li W; Mo Z; Hu Y
    Sci Rep; 2017 Oct; 7(1):14200. PubMed ID: 29079774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of gene expression on survival of clear cell renal cell carcinoma.
    Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
    Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma.
    Kang HW; Park H; Seo SP; Byun YJ; Piao XM; Kim SM; Kim WT; Yun SJ; Jang W; Shon HS; Ryu KH; Lee SC; Kim WJ; Kim YJ
    J Korean Med Sci; 2019 May; 34(19):e144. PubMed ID: 31099194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma.
    Liu M; Pan Q; Xiao R; Yu Y; Lu W; Wang L
    Sci Rep; 2020 Jul; 10(1):12949. PubMed ID: 32737333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
    Tang W; Cao Y; Ma X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
    Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
    BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Mo S; Su Z; Heng B; Chen W; Shi L; Du X; Lai C
    J Nippon Med Sch; 2018; 85(2):78-86. PubMed ID: 29731501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
    Hu CY; Mohtat D; Yu Y; Ko YA; Shenoy N; Bhattacharya S; Izquierdo MC; Park AS; Giricz O; Vallumsetla N; Gundabolu K; Ware K; Bhagat TD; Suzuki M; Pullman J; Liu XS; Greally JM; Susztak K; Verma A
    Clin Cancer Res; 2014 Aug; 20(16):4349-60. PubMed ID: 24916699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.